The resulting degrader 80 displayed substantial degradation potential towards BRD4 and could also inhibit the growth of tumor as evidenced in an in vivo murine hind-limb xenograft model with human MV4-11 leukemia cells [319]. Here, BRD4 is linked to leukemia.